Solasia Pharma K.K. (TYO:4597)
29.00
-2.00 (-6.45%)
Aug 25, 2026, 3:30 PM JST
Solasia Pharma K.K. Revenue
Solasia Pharma K.K. had revenue of 2.00M JPY in the quarter ending June 30, 2026, a decrease of -91.67%. This brings the company's revenue in the last twelve months to 388.00M, up 32.42% year-over-year. In the year 2025, Solasia Pharma K.K. had annual revenue of 429.00M with 35.76% growth.
Revenue (ttm)
388.00M
Revenue Growth
+32.42%
P/S Ratio
20.41
Revenue / Employee
17.64M
Employees
22
Market Cap
7.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 429.00M | 113.00M | 35.76% |
| Dec 31, 2024 | 316.00M | -301.00M | -48.78% |
| Dec 31, 2023 | 617.00M | -475.00M | -43.50% |
| Dec 31, 2022 | 1.09B | 533.00M | 95.35% |
| Dec 31, 2021 | 559.00M | 105.00M | 23.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 67.00B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Daito Pharmaceutical | 50.65B |
| Nippon Chemiphar | 33.02B |
| Koa Shoji Holdings | 24.68B |
| Morishita Jintan | 12.82B |
| Mizuho Medy | 10.82B |
| Wakamoto Pharmaceutical | 9.43B |